Violence Intervention Programs for Gunshot Wounds
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new program, called Houston-HVIP, can improve recovery after a gunshot wound and prevent future injuries. It compares this approach to the usual care for individuals affected by community violence. Researchers seek to understand if this program can enhance mental and physical health over a year. The study is recruiting English or Spanish speakers treated for a gunshot wound at Memorial Hermann Hospital who reside in Harris County. As an unphased trial, participants have the opportunity to contribute to innovative care strategies that could enhance recovery and prevent future injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Houston-HVIP treatment is safe?
Research has shown that programs like the Houston-HVIP, which assist people in hospitals after violent incidents, can reduce the risk of future injuries. Although specific information on side effects or safety issues for the Houston-HVIP is unavailable, such programs typically provide counseling and support. They aim to enhance mental, emotional, and physical health. Since the program does not involve medication or medical procedures, the risk of negative effects remains very low. Participants often feel supported and empowered, rather than experiencing harm. Overall, these hospital-based programs are considered safe and are generally well-received by participants.12345
Why are researchers excited about this trial?
Researchers are excited about the Houston-HVIP treatment for gunshot wound victims because it takes a comprehensive approach beyond just medical care. Unlike standard treatments that focus primarily on physical healing, this program emphasizes violence intervention and prevention, aiming to address the root causes of gun violence. By incorporating social support, counseling, and rehabilitation services, Houston-HVIP seeks to reduce the likelihood of future violence and hospital readmissions, offering a holistic recovery path for patients.
What evidence suggests that the Houston-HVIP treatment could be effective for preventing violent reinjury?
Research has shown that hospital-based violence intervention programs (HVIPs) are promising in reducing repeat violence. These programs engage patients when they are most open to change, often during hospital stays for injuries from violence. Studies have found that HVIPs can lower the risk of re-injury and improve both mental and physical health. In this trial, participants may receive the Houston-HVIP treatment, which is being evaluated for its effectiveness. Although specific data on the Houston-HVIP is not yet available, the success of similar programs suggests it could be effective. Early evidence supports that these programs can lead to safer outcomes for people involved in violence.12367
Who Is on the Research Team?
Alexander Testa, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Sandra McKay, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for adults treated at Memorial Hermann Hospital in Houston for gunshot wounds from community violence. Participants must speak English or Spanish and give informed consent. It excludes those with self-inflicted, accidental, unintentional, or domestic violence-related gunshot injuries.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the Houston-HVIP program to reduce repeat violent events and improve mental and behavioral health
Follow-up
Participants are monitored for changes in post-traumatic stress, aggression, and general health
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Case Management
- Houston-HVIP treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator